SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001636050-18-000007
Filing Date
2018-02-09
Accepted
2018-02-09 16:18:21
Documents
49
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q a12311710qaxovant.htm 10-Q 933489
2 EXHIBIT 31.1 a123117exhibit311.htm EX-31.1 10096
3 EXHIBIT 31.2 a123117exhibit312.htm EX-31.2 10029
4 EXHIBIT 32.1 a123117exhibit321.htm EX-32.1 6326
5 EXHIBIT 32.2 a123117exhibit322.htm EX-32.2 6307
  Complete submission text file 0001636050-18-000007.txt   2870998

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT axon-20171231.xml EX-101.INS 292289
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axon-20171231.xsd EX-101.SCH 25595
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axon-20171231_cal.xml EX-101.CAL 43710
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axon-20171231_def.xml EX-101.DEF 107238
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axon-20171231_lab.xml EX-101.LAB 341111
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axon-20171231_pre.xml EX-101.PRE 191487
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS 441-295-5950
Axovant Sciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37418 | Film No.: 18591971
SIC: 2834 Pharmaceutical Preparations